首页> 美国卫生研究院文献>Respiration >Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone

【2h】

Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone

机译：吡非尼酮治疗特发性肺纤维化患者的抗酸治疗和疾病进展

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundGastroesophageal reflux disease is a potential risk factor for idiopathic pulmonary fibrosis (IPF) progression; however, the impact of antacid therapy (AAT) is under debate.

机译：背景胃食管反流病是特发性肺纤维化（IPF）进展的潜在危险因素。然而，抗酸剂治疗（AAT）的影响尚在争论中。

著录项

期刊名称 Respiration
作者
Michael Kreuter; Paolo Spagnolo; Wim Wuyts; Elisabetta Renzoni; Dirk Koschel; Francesco Bonella; Toby M. Maher; Martin Kolb; Derek Weycker; Klaus-Uwe Kirchgässler; Ulrich Costabel;
展开▼
作者单位

展开▼
年(卷),期 -1(93),6
年度 -1
页码 415–423
总页数 10
原文格式 PDF
正文语种
中图分类呼吸生理学;
关键词
Antacid therapy Gastroesophageal reflux disease Idiopathic pulmonary fibrosis Pirfenidone Progression-free survival;

机译：抗酸疗法;胃食管反流病;特发性肺纤维化;吡非尼酮;无进展生存;

相似文献

外文文献
中文文献
专利

1. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone [J] . Kreuter Michael, Spagnolo Paolo, Wuyts Wim, Respiration: International Review of Thoracic Diseases . 2017,第6期

机译：抗酸性肺纤维化患者的抗酸治疗和疾病进展，接受Pirfenidone的特发性肺纤维化
2. ANTACID THERAPY AND DISEASE PROGRESSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) UNDER PIRFENIDONE TREATMENT [J] . Kreuter M., Spagnolo P., Wuyts W., Thorax: The Journal of the British Thoracic Society . 2016,第Suppla3期

机译：吡非尼酮治疗的特发性肺纤维化（IPF）患者的抗酸治疗和疾病进展
3. Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis [J] . Steven D. Nathan, Ulrich Costabel, Ian Glaspole, Chest . 2019,第4期

机译：吡非尼酮在特发性肺纤维化患者多种疾病进展事件中的疗效
4. Acoustic evaluation of pirfenidone on patients with combined pulmonary fibrosis emphysema syndrome [C] . Sonia Charleston-Villalobos, Norma Castañeda-Villa, Ramón Gonzàlez-Camarena, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：吡非尼酮对合并肺纤维化性肺气肿综合征的声学评价
5. Correlation of Vascular Leak Measured Using Gadofosveset-Enhanced Lung Magnetic Resonance Imaging with Radiographic and Physiologic Measures of Fibrosis in Patients with Idiopathic Pulmonary Fibrosis. [D] . Liang, Lloyd. 2018

机译：特发性肺纤维化患者使用Gadofosveset增强肺磁共振成像测得的血管渗漏与纤维化的放射学和生理学指标的相关性。
6. Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry [O] . Colin H. Holtze, Elizabeth A. Freiheit, Susan L. Limb, 2020

机译：在美国使用吡非尼酮和nintedanib相关的患者和部位特征；肺纤维化基金会患者登记处登记的特发性肺纤维化患者的分析
7. Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis who received pirfenidone [O] . Kreuter, M, Spagnolo, P, Wuyts, W, 2017

机译：接受吡非尼酮治疗的特发性肺纤维化患者的抗酸治疗和疾病进展

Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone

摘要

著录项

相似文献

相关主题

期刊订阅